RUA Life Sciences plc (AIM:RUA)

Market Cap	12.10M +66.0%
Revenue (ttm)	4.46M +74.5%
Net Income	-145.33K
EPS	-0.00
Shares Out	62.06M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	33,000
Open	19.90
Previous Close	19.50
Day's Range	19.85 - 19.90
52-Week Range	10.42 - 26.80
Beta	0.96
Analysts	Strong Buy
Price Target	50.00 (+151.89%)
Earnings Date	Jun 25, 2026

About RUA Life Sciences

RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufacture, Vascular, and Structural Heart. The company acts as the depository of intellectual property and licensing rights to various biostable and implantable polymers, including Elast-Eon and ECSil; and provides sub-contract manufacturing, assembly, packing, and services of medical device, as well as implantable fabric. It also enga...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1996
• Employees: 59
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: RUA

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 17, 2026

Data Sources Report a data error